132 related articles for article (PubMed ID: 23260351)
1. Design and synthesis of 2-(3-alkylaminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-ones as potent antitumor agents.
Huang SM; Cheng YY; Chen MH; Huang CH; Huang LJ; Hsu MH; Kuo SC; Lee KH
Bioorg Med Chem Lett; 2013 Feb; 23(3):699-701. PubMed ID: 23260351
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and preclinical evaluation of new 5,6- (or 6,7-) disubstituted-2-(fluorophenyl)quinolin-4-one derivatives as potent antitumor agents.
Chou LC; Tsai MT; Hsu MH; Wang SH; Way TD; Huang CH; Lin HY; Qian K; Dong Y; Lee KH; Huang LJ; Kuo SC
J Med Chem; 2010 Nov; 53(22):8047-58. PubMed ID: 20973552
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead.
Cheng YY; Liu CY; Tsai MT; Lin HY; Yang JS; Wu TS; Kuo SC; Huang LJ; Lee KH
Bioorg Med Chem Lett; 2013 Sep; 23(18):5223-7. PubMed ID: 23916255
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
Zhou Y; Yan W; Cao D; Shao M; Li D; Wang F; Yang Z; Chen Y; He L; Wang T; Shen M; Chen L
Eur J Med Chem; 2017 Sep; 138():1114-1125. PubMed ID: 28763646
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antiproliferative activity of new phenylaminoisoquinolinequinones against cancer cell lines.
Delgado V; Ibacache A; Arancibia V; Theoduloz C; Valderrama JA
Molecules; 2013 Jan; 18(1):721-34. PubMed ID: 23299551
[TBL] [Abstract][Full Text] [Related]
9. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
[TBL] [Abstract][Full Text] [Related]
10. De novo design, synthesis and biological evaluation of 1,4-dihydroquinolin-4-ones and 1,2,3,4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors.
Jiang C; Yang L; Wu WT; Guo QL; You QD
Bioorg Med Chem; 2011 Sep; 19(18):5612-27. PubMed ID: 21856161
[TBL] [Abstract][Full Text] [Related]
11. Copper(I)-Catalyzed Nitrile-Addition/
Hsueh WY; Lee YE; Huang MS; Lai CH; Gao YS; Lin JC; Chen YF; Chang CL; Chou SY; Chen SF; Lu YY; Chang LH; Lin SF; Lin YH; Hsu PC; Wei WY; Huang YC; Kao YF; Teng LW; Liu HH; Chen YC; Yuan TT; Chan YW; Huang PH; Chao YT; Huang SY; Jian BH; Huang HY; Yang SC; Lo TH; Huang GR; Wang SY; Lin HS; Chuang SH; Huang JJ
J Med Chem; 2021 Feb; 64(3):1435-1453. PubMed ID: 33492141
[TBL] [Abstract][Full Text] [Related]
12. Novel angular furoquinolinones bearing flexible chain as antitumor agent: design, synthesis, cytotoxic evaluation, and DNA-binding studies.
Xie L; Qian X; Cui J; Xiao Y; Wang K; Wu P; Cong L
Bioorg Med Chem; 2008 Sep; 16(18):8713-8. PubMed ID: 18722129
[TBL] [Abstract][Full Text] [Related]
13. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study.
Foroumadi A; Emami S; Rajabalian S; Badinloo M; Mohammadhosseini N; Shafiee A
Biomed Pharmacother; 2009 Mar; 63(3):216-20. PubMed ID: 18328669
[TBL] [Abstract][Full Text] [Related]
14. Novel Pyrazolo[4, 3-c]Quinolin-3-One Derivatives as PDE5A Inhibitors.
Shaik A; Agarwal HK; Bhakuni R; Kirubakaran S
Curr Top Med Chem; 2019; 19(4):305-315. PubMed ID: 30747070
[TBL] [Abstract][Full Text] [Related]
15. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
Gasparotto V; Castagliuolo I; Ferlin MG
J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
[TBL] [Abstract][Full Text] [Related]
16. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
17. 1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells.
Liu YM; Lee HY; Chen CH; Lee CH; Wang LT; Pan SL; Lai MJ; Yeh TK; Liou JP
Eur J Med Chem; 2015 Jan; 89():320-30. PubMed ID: 25462248
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).
Satyanarayana M; Feng W; Cheng L; Liu AA; Tsai YC; Liu LF; LaVoie EJ
Bioorg Med Chem; 2008 Aug; 16(16):7824-31. PubMed ID: 18676151
[TBL] [Abstract][Full Text] [Related]
20. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
Metwally K; Pratsinis H; Kletsas D
Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
